您当前的位置：
首页 >
文章列表页 >
Expert consensus on artificial intelligence methods based on multimodal data for predicting adverse drug reactions of antineoplastics
更新时间：2026-07-28

    • Expert consensus on artificial intelligence methods based on multimodal data for predicting adverse drug reactions of antineoplastics

    • ZHONGGUO YAOFANG   Vol. 37, Issue 14, Pages: 1797-1804(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.14.01    

      CLC： R95;R951

    • Received：18 March 2026，

      Revised：2026-07-07，

      Accepted：08 July 2026，

      Online First：24 July 2026，

      Published：30 July 2026

    移动端阅览

  • .Expert consensus on artificial intelligence methods based on multimodal data for predicting adverse drug reactions of antineoplastics[J].ZHONGGUO YAOFANG,2026,37(14):1797-1804. DOI： 10.6039/j.issn.1001-0408.2026.14.01.

  •  
  •  

0

Views

4

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Analysis of the incidence and associated factors of cyclosporine-associated acute kidney injury in hospitalized patients based on real-world data
Study on the efficacy and rotation pattern of Hydromorphone hydrochloride extended-release tablets in the treatment of chronic cancer-related pain
Applications and prospects of prompt engineering in pharmaceutical popularization
Incentive and constraint factors and optimization strategies for artificial intelligence application in pharmacy based on TAM-TOE-DOI integrated framework
Construction and practice of application model for localized large language model in preoperative medication reconciliation for gastric cancer

Related Author

LI Xiao
LI Hanbing
HUANG Xin
SUN Yanying
WANG Xue
LAO Jiahui
DOU Yaqing
YANG Lin

Related Institution

Healthcare Big Data Center， the First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital
Dept. of Clinical Pharmacy， the First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital
College of Pharmaceutical Sciences， Zhejiang University of Technology
Clinical Oncology School of Fujian Medical University， Fujian Cancer Hospital
Dept. of Pharmacy，The Second Affiliated Hospital of Chongqing Medical University
0